Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
Phase 2
40
about 2.3 years
18–75
1 site in NY
About this study
This trial is testing a new treatment to improve chronic migraine symptoms. The treatment involves an infusion of lidocaine into blood vessels in the skull to numb pain receptors, potentially reducing migraine intensity, frequency, and duration.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Lidocaine (drug)
- 2.Undergo Lidocaine Procedure
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
lidocaine, local anesthetic (Blocks sodium channels to numb tissue locally)
topical (Topical Cream)
Secondary: Adverse events at 24 hours and 3 months post-procedure., Mean change from baseline in the Global Assessment of Migraine Severity (GAMS) at 3 months, Sustained freedom from headache pain >48hrs.
Neurology